FDA Adverse Event Injury Summary report: N

HERO GRAFT

MDR report key: 3946043 · Received July 21, 2014

Report

Report Number
3006945290-2014-00051
Event Type
Injury
Date Received
July 21, 2014
Report Date
June 19, 2014
Manufacturer
HEMOSPHERE, INC.
Product Code
DSY
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
OH, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

THIS INVESTIGATION IS CURRENTLY ONGOING. ANY ADDITIONAL INFORMATION WILL BE PROVIDED IN THE FOLLOW-UP REPORT.

Additional Manufacturer Narrative · 1

ACCORDING TO A MANUSCRIPT, THE END STAGE OF DIALYSIS ACCESS: FEMORAL GRAFT OR HERO VASCULAR ACCESS DEVICE, AN ARTERIAL GRAFT COMPONENT (AGC) BECAME INFECTED SIX WEEKS POST IMPLANT. WITHOUT INFORMATION ABOUT THE SOURCE OF THE INFECTION, TYPE OF INFECTION, PATIENT COMORBIDITIES, AND PRE-EXISTING INFECTIONS; THE RELATIONSHIP OF THE INFECTION TO THE HERO GRAFT DEVICE IN DR. (B)(6) PATIENT CANNOT BE DETERMINED. INFECTION IS A KNOWN POTENTIAL COMPLICATION LISTED IN THE HERO GRAFT INSTRUCTIONS FOR USE (IFU). THE HERO GRAFT IFU CONTRAINDICATES USE OF THE HERO DEVICE IN PATIENTS WITH KNOWN PREEXISTING BACTEREMIA. IN ADDITION, INSTRUCTIONS FOR SCREENING BLOOD CULTURES TO RULE OUT ASYMPTOMATIC BACTEREMIA AND RECOMMENDED ANTIBIOTIC THERAPY ARE ALSO PROVIDED IN THE IFU. THERE IS NO INDICATION THAT AN ERROR OR DEFICIENCY OCCURRED AT CRYOLIFE AND THE IFU ADEQUATELY COMMUNICATES RISK.

Description of Event or Problem · 1

ACCORDING TO A MANUSCRIPT, THE END STAGE OF DIALYSIS ACCESS: FEMORAL GRAFT OR HERO VASCULAR ACCESS DEVICE, A PATIENT DEVELOPED A GRAFT INFECTION AFTER HERO GRAFT IMPLANT.

Description of Event or Problem · 1

ACCORDING TO A MANUSCRIPT, THE END STAGE OF DIALYSIS ACCESS: FEMORAL GRAFT OR HERO VASCULAR ACCESS DEVICE, A PATIENT DEVELOPED A GRAFT INFECTION AFTER HERO GRAFT IMPLANT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
426027 HERO GRAFT VASCULAR GRAFT PROSTHESIS DSY HEMOSPHERE, INC. HERO 1002

Patients

Seq Age Sex Outcome Treatment
1 Other